欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/3112/003
药品名称
Deferasirox Pharmathen
活性成分
DEFERASIROX 360.0 mg
剂型
Film-coated tablet
上市许可持有人
Pharmathen SA 6, Dervenakion st Pallini, Attiki 15351 Greece
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
Greece (GR)
Cyprus (CY)
Deferasirox Pharmathen 360mg FCT
United Kingdom (Northern Ireland) (XI)
Germany (DE)
Deferasirox/Pharmathen 360 mg Filmtabletten
Belgium (BE)
Deferasirox Pharmathen 360 mg comprimés pelliculés
Ireland (IE)
Austria (AT)
France (FR)
Spain (ES)
许可日期
2021/11/30
最近更新日期
2024/03/21
药物ATC编码
V03AC03 deferasirox
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Labelling
|
common_outer_90_180_360mg_en_clean
Date of last change:2024/09/06
Final PL
|
common_pil_90_180_360mg_en_clean
Date of last change:2024/09/06
Final SPC
|
common_spc_90_180_360mg_en_clean
Date of last change:2024/09/06
PubAR
|
PAR Deferasirox Pharmathen film coated tablet 90 mg 180 mg and 360 mg_ DK_H_3112_001_002_003_DC
Date of last change:2024/09/06
PubAR Summary
|
sPAR Deferasirox Pharmathen film coated tablet 90 mg 180 mg and 360 mg_ DK_H_3112_001_002_003_DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase